Aureo de Almeida Delgado

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
CONTEXT Tumor necrosis factor-alpha (TNF-α) inhibitor therapy plays a pivotal role in the management of moderate to severe inflammatory bowel disease. Because of the role of TNF-α in the host defenses, anti-TNF therapy has been associated with an increase the risks of granulomatous infections. OBJECTIVE To report the first case of adalimumab-associated(More)
  • 1